Filter by tags: Clinical trial Biology Clear all tag filters
2 news articles found
There are important lessons to be learned from the approaches that led to the rapid deployment of vaccines in the fight against the COVID-19 pandemic, James Naismith, professor of structural biology at the University of Oxford and director of the Rosalind Franklin Institute, told World Nuclear Association's Thinking Outside the Dome - Strategic eForum on Nuclear Innovation. The following is the text of his speech.
- Source: World Nuclear News
- Date: Friday, 25 June 2021
- Original article: world-nuclear-news.org/Articles/SPEECH-Learning-lessons-from-vaccine-development
A new radioactive version of the element scandium has been produced in Australia's OPAL reactor for the first time. Scandium-47 has the potential for theranostic use, that is, both as a therapeutic drug and a diagnostic agent, and has similar properties to lutetium-177, which is already being used in clinical trials.
- Source: World Nuclear News
- Date: Friday, 20 March 2020
- Original article: world-nuclear-news.org/Articles/Australia-produces-first-batch-of-medical-isotope